Disease · MONDO_0043797
Trials73
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 3 more are not shown, since the checks do not confirm them.
1 to 20 of 73
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00407745 | A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury | Phase 3 | 220 | 2011-12-08 | Neuralgia, Spinal Cord Injuries | PREGABALIN | Its record names the disease | ClinicalTrials.gov |
| NCT01426555 | FES-Rowing Versus Zoledronic Acid to Improve Bone Health in Spinal Cord Injury (SCI) | Phase 2/3 | 70 | 2016-03-10 | Osteoporosis | ZOLEDRONIC ACID | Its record names the disease | ClinicalTrials.gov |
| NCT01225055 | Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury | Phase 2 | 60 | 2017-06-22 | Spinal Cord Injury, Bone Loss, Osteoporosis | TERIPARATIDE | Its record names the disease | ClinicalTrials.gov |
| NCT05639946 | Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial | Phase 3 | 44 | 2026-03-18 | Spinal Cord Injuries, Neuropathic Pain | BRIVARACETAM | Its record names the disease | ClinicalTrials.gov |
| NCT00439140 | Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder | Phase 3 | 41 | 2014-01-24 | Overactive Bladder | ONABOTULINUMTOXINA | Its record names the disease | ClinicalTrials.gov |
| NCT00750061 | Efficacy and Safety of Lithium Carbonate in the Treatment of Chronic Spinal Cord Injuries | Phase 2 | 40 | 2015-05-04 | Spinal Cord Injury | LITHIUM CARBONATE | Its record names the disease | ClinicalTrials.gov |
| NCT00755079 | Use of an Oral Beta-2 Agonist in Persons With Spinal Cord Injury | Phase 2/3 | 40 | 2014-07-16 | Spinal Cord Injury | ALBUTEROL | Its record names the disease | ClinicalTrials.gov |
| NCT02323698 | Effects of Caffeine and Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury | Phase 1/2 | 36 | 2022-08-09 | Spinal Cord Injuries | CAFFEINE | Its record names the disease | ClinicalTrials.gov |
| NCT00266864 | Testosterone Replacement Therapy in Chronic Spinal Cord Injury | Phase 2/3 | 31 | 2014-04-07 | Spinal Cord Injury, Hypogonadism | TESTOSTERONE | Its record names the disease | ClinicalTrials.gov |
| NCT01652040 | Resistance Training and Testosterone After Spinal Cord Injury | Phase 2/3 | 26 | 2018-05-03 | Spinal Cord Injury | TESTOSTERONE | Its record names the disease | ClinicalTrials.gov |
| NCT02025179 | 12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI) | Phase 2 | 25 | 2018-09-25 | Spinal Cord Injury, Bone Loss, Osteoporosis | TERIPARATIDE | Its record names the disease | ClinicalTrials.gov |
| NCT04379011 | Brivaracetam to Reduce Neuropathic Pain in Chronic Spinal Cord Injury | Phase 1/2 | 24 | 2025-04-27 | Spinal Cord Injuries | BRIVARACETAM | Its record names the disease | ClinicalTrials.gov |
| NCT02195895 | Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide | Phase 2 | 17 | 2018-09-26 | Spinal Cord Injury, Bone Loss, Osteoporosis | ALENDRONIC ACID | Its record names the disease | ClinicalTrials.gov |
| NCT05041322 | Improving Ventilatory Capacity in Those With Chronic High Level SCI | Phase 2 | 13 | 2025-09-18 | Spinal Cord Injuries | BUSPIRONE | Its record names the disease | ClinicalTrials.gov |
| NCT03345576 | Testosterone and Long Pulse Stimulation After SCI | Phase 2 | 12 | 2024-12-11 | Spinal Cord Injury | TESTOSTERONE | Its record names the disease | ClinicalTrials.gov |
| NCT02441660 | Capsaicin 8% Patch for Spinal Cord Injury Neuropathic Pain | Not applicable | 11 | 2022-10-06 | Spinal Cord Injuries, Neuropathic Pain | CAPSAICIN | Its record names the disease | ClinicalTrials.gov |
| NCT02736890 | Injecting Botulinum Toxin A Underneath the Skin to Treat Spinal Cord Pain in Patients With Spinal Cord Injury | Phase 2 | 8 | 2019-04-09 | Neuropathic Back Pain, Spinal Cord Injury | ONABOTULINUMTOXINA | Its record names the disease | ClinicalTrials.gov |
| NCT02524379 | Spinal Cord Injury Neuroprotection With Glyburide | Phase 1/2 | 3 | 2022-06-07 | Acute Spinal Cord Injury | GLYBURIDE | Its record names the disease | ClinicalTrials.gov |
| NCT00004759 | Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury | Phase 3 | 497 | Spinal Cord Injury | METHYLPREDNISOLONE, TIRILAZAD | Its record names the disease | ClinicalTrials.gov | |
| NCT01813240 | Prevention of Imminent Paralysis Following Spinal Cord Trauma or Ischemia by Minocycline: A Multi-center Study in Israel With IDF Primary Care Involvement | Phase 2/3 | 444 | Spinal Tumors, Trauma Patients, Minocycline. | MINOCYCLINE | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0043797/trials